Cancer Incidence and Mortality for Genesee County, 2012-2016

Source: New York State Cancer Registry

Site of Cancer Incidence Mortality
Males and Females Males Females Males and Females Males Females
Average Annual Cases Rate per 100,000 Population 95% CI Average Annual Cases Rate per 100,000 Males 95% CI Average Annual Cases Rate per 100,000 Females 95% CI Average Annual Deaths Rate per 100,000 Population 95% CI Average Annual Deaths Rate per 100,000 Males 95% CI Average Annual Deaths Rate per 100,000 Females 95% CI
All Invasive Malignant Tumors 393.0 507.2 484.4-530.9 193.2 528.9 495.3-564.3 199.8 495.1 463.7-528.3 132.6 166.4 153.7-180.0 68.8 195.1 174.7-217.3 63.8 147.6 131.2-165.7
Oral cavity and pharynx 10.6 13.8 10.3-18.3 7.8 20.9 14.8-29.0 2.8 7.6 4.0-13.1 1.8 2.3 1.0-4.5 1.4 4.1 1.6-8.7 0.4 0.8 0.1-3.8
Esophagus 2.8 3.6 1.9-6.2 2.4 6.4 3.3-11.6 0.4 0.9 0.1-4.0 2.4 3.1 1.6-5.6 2.0 5.5 2.6-10.4 0.4 1.0 0.1-4.2
Stomach 4.8 6.2 3.9-9.4 2.8 7.2 3.9-12.5 2.0 5.6 2.5-10.8 2.2 2.7 1.3-5.0 1.8 5.1 2.3-10.1 0.4 0.8 0.1-3.7
Colorectal 28.6 37.8 31.7-44.9 16.2 47.4 37.4-59.3 12.4 30.0 22.8-38.9 10.8 13.7 10.2-18.2 6.8 19.7 13.6-27.9 4.0 9.6 5.6-15.5
Colon excluding rectum 19.4 25.5 20.6-31.4 10.6 31.8 23.6-41.9 8.8 20.5 14.8-27.9 8.4 10.9 7.7-14.9 5.4 15.7 10.3-23.2 3.0 7.0 3.7-12.3
Rectum & rectosigmoid 9.2 12.3 8.9-16.6 5.6 15.6 10.3-23.0 3.6 9.5 5.5-15.6 2.4 2.9 1.5-5.3 1.4 4.0 1.6-8.6 1.0 2.5 0.8-6.5
Liver / intrahepatic bile duct 4.8 6.0 3.8-9.2 3.0 7.3 4.0-12.5 1.8 4.7 2.1-9.4 2.6 3.1 1.6-5.4 1.6 4.1 1.8-8.6 1.0 2.0 0.6-5.4
Pancreas 10.4 12.9 9.6-17.2 5.0 13.3 8.5-20.0 5.4 12.2 7.9-18.3 8.6 10.5 7.6-14.3 4.4 12.2 7.6-18.7 4.2 8.9 5.4-14.1
Larynx 3.6 4.3 2.5-7.0 2.6 6.2 3.3-11.0 1.0 2.5 0.8-6.2 0.8 1.0 0.3-2.7 0.8 2.1 0.6-5.7 0.0 0.0 0.0-2.6
Lung and bronchus 58.8 73.6 65.3-82.8 27.0 73.0 61.0-86.9 31.8 76.2 64.5-89.5 43.8 54.9 47.7-63.0 21.8 60.7 49.7-73.7 22.0 52.2 42.7-63.5
Melanoma of the skin 18.6 24.2 19.4-30.0 13.4 36.5 28.0-46.9 5.2 13.7 8.8-20.6 2.0 2.5 1.2-4.9 1.8 4.7 2.0-9.4 0.2 0.5 0.0-3.3
Female breast             55.4 139.6 123.1-157.9             7.6 18.1 12.6-25.4
Cervix uteri             1.8 4.4 1.9-8.9             0.8 2.8 0.7-7.3
Corpus uterus and NOS             14.8 33.8 26.4-42.9             2.4 5.0 2.5-9.4
Ovary             5.8 14.4 9.5-21.3             3.0 7.1 3.9-12.2
Prostate       42.0 107.9 93.5-124.0             4.6 13.8 8.7-20.9      
Testis       2.2 8.1 4.0-14.5             0.0 0.0 0.0-2.6      
Urinary bladder (incl. in situ) 24.2 30.4 25.2-36.5 17.4 48.6 38.8-60.3 6.8 15.3 10.5-21.8 4.8 5.7 3.6-8.7 3.0 9.0 5.0-15.1 1.8 3.7 1.6-7.6
Kidney and renal pelvis 15.4 19.8 15.4-25.0 9.8 27.1 19.8-36.4 5.6 14.1 9.2-20.9 3.2 4.0 2.3-6.8 2.6 7.6 4.0-13.4 0.6 1.4 0.3-4.6
Brain and other central nervous system 5.8 8.0 5.2-11.7 3.2 8.9 5.0-14.9 2.6 7.4 3.8-13.1 3.4 4.5 2.5-7.4 2.2 6.5 3.1-12.0 1.2 2.6 1.0-6.3
Thyroid 8.4 13.3 9.4-18.1 2.8 8.4 4.5-14.4 5.6 18.7 12.2-27.4 0.6 0.8 0.2-2.5 0.2 0.6 0.0-3.8 0.4 1.0 0.1-4.2
Hodgkin lymphoma 2.2 3.9 1.9-7.0 0.8 3.3 0.9-8.2 1.4 4.5 1.8-9.4 0.0 0.0 0.0-1.3 0.0 0.0 0.0-2.6 0.0 0.0 0.0-2.6
Non-Hodgkin lymphomas 14.4 18.7 14.6-23.9 6.2 17.6 11.8-25.4 8.2 20.0 14.1-27.7 4.2 5.4 3.3-8.5 2.2 6.9 3.4-12.5 2.0 4.7 2.2-9.3
Myeloma 5.6 7.3 4.8-10.7 2.0 5.4 2.5-10.3 3.6 9.0 5.2-14.7 2.8 3.3 1.8-5.7 1.0 2.9 0.9-7.1 1.8 3.7 1.6-7.6
Leukemias 15.0 19.6 15.3-24.9 8.8 24.7 17.8-33.5 6.2 14.5 9.6-21.3 5.6 7.2 4.7-10.6 3.2 9.5 5.4-15.6 2.4 5.4 2.6-10.3

Notes

  • Incidence data are provisional, November 2018.
  • Rates are per 100,000 persons, age-adjusted to the 2000 US standard population, with 95% confidence intervals.
  • Rates based on fewer than 4 cases or deaths per year are unstable and should be used with caution. NOS = Not otherwise specified.